Performance Evaluation of Capsule Endoscopy in the Diagnosis of Gluten Sensitive Enteropathy (MA-23)
1 other identifier
observational
102
3 countries
5
Brief Summary
The purpose of this study is to determine how well capsule endoscopy identifies changes in the small bowel mucosa of celiac disease patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2003
Typical duration for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2007
CompletedFirst Submitted
Initial submission to the registry
November 8, 2007
CompletedFirst Posted
Study publicly available on registry
November 9, 2007
CompletedJuly 31, 2019
November 1, 2007
November 8, 2007
July 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The number of findings identified during the capsule endoscopy or upper GI endoscopy procedure, and which were considered by the investigator as related to the gluten sensitive enteropathy origin
within 14 days of enrollment
Secondary Outcomes (1)
Longitudinal extent of villous changes in the small bowel will be evaluated.
within 14 days of enrollment
Interventions
Given® Diagnostic system with Pillcam SB
Eligibility Criteria
clinic paitnets with known Gluten sensitivity (Celaic).
You may qualify if:
- Patient age is 18 years or older
- Patient agrees to sign the Informed Consent Form
- Patient has positive celiac serology or negative celiac serology + IgA deficiency and suffers from one or more of the following symptoms and/or abdominal biochemical values:
- Chronic diarrhea
- Weight loss
- Abdominal cramps
- History of spontaneous abortion
- Iron deficiency anemia
- Osteoporosis
- Infertility
- Hypoalbuminaemia
- Low cholesterol
- Low prothrombin activity
You may not qualify if:
- Patient is known or is suspected to suffer from intestinal obstruction.
- Patient has a cardiac pacemaker or other electro-medical device.
- Patient suffers from severe swallowing disorder or Zenker's diverticulum
- Patient has any condition, which precludes compliance with study and/or device instructions.
- Female patient is pregnant
- Patient suffers from life threatening conditions
- Patient is currently participating in another clinical study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medtronic - MITGlead
Study Sites (5)
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, 01655, United States
University of Tampere Medical School
Tampere, Finland
Ospedale Maggiore - Policlinico
Milan, 20122, Italy
Universita Cattolica del Sacro Cuore
Rome, Italy
San Giovanni A.S. Hospital
Torino, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roberto de Franchis, MD, Prof.
Ospedale Maggiore - Policlinico, Milano, Italy
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 8, 2007
First Posted
November 9, 2007
Study Start
November 1, 2003
Study Completion
July 1, 2007
Last Updated
July 31, 2019
Record last verified: 2007-11